Literature DB >> 8609498

The non-structural proteins of bluetongue virus are a dominant source of cytotoxic T cell peptide determinants.

L D Jones1, T Chuma, R Hails, T Williams, P Roy.   

Abstract

Virus-specific, CD8+ cytotoxic T lymphocytes (CTLs) were generated in two strains of mice (BALB/c, CBA/Ca) against bluetongue virus serotype 10 (BTV-10). Recombinant vaccinia viruses (VV) expressing the individual structural and non-structural proteins of BTV were used to infect syngeneic target cells. We found that in both BALB/c (H-2d) and CBA/Ca (H-2k) mice, polyclonal CTL populations recognized target cells expressing the non-structural proteins better than those expressing the structural proteins. CTLs generated against other BTV serotypes also predominantly recognized the non-structural proteins. However, the extent of cross-reactivity was dependent on the H-2 background of the animals immunized. No CTLs cross-reactive to the BTV-10 heterotype were demonstrated with the panel of molecularly cloned recombinants in the H-2d haplotype. The outer capsid proteins VP2 and VP5 which vary considerably between serotypes were not recognized by heterotypic CTLs. Using this murine model we have determined which BTV proteins are the major targets of the CTL response. The implications for the design and development of subunit vaccines are discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8609498     DOI: 10.1099/0022-1317-77-5-997

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  10 in total

1.  Purification, stability, and immunogenicity analyses of five bluetongue virus proteins for use in development of a subunit vaccine that allows differentiation of infected from vaccinated animals.

Authors:  Jenna Anderson; Emmanuel Bréard; Karin Lövgren Bengtsson; Kjell-Olov Grönvik; Stéphan Zientara; Jean-Francois Valarcher; Sara Hägglund
Journal:  Clin Vaccine Immunol       Date:  2014-01-22

2.  Baculovirus-expressed nonstructural protein NS2 of bluetongue virus induces a cytotoxic T-cell response in mice which affords partial protection.

Authors:  L D Jones; T Williams; D Bishop; P Roy
Journal:  Clin Diagn Lab Immunol       Date:  1997-05

3.  Evaluation of the immunogenicity of an experimental subunit vaccine that allows differentiation between infected and vaccinated animals against bluetongue virus serotype 8 in cattle.

Authors:  Jenna Anderson; Sara Hägglund; Emmanuel Bréard; Loic Comtet; Karin Lövgren Bengtsson; John Pringle; Stéphan Zientara; Jean Francois Valarcher
Journal:  Clin Vaccine Immunol       Date:  2013-05-29

4.  Oncolytic bluetongue viruses: promise, progress, and perspectives.

Authors:  Joseph K-K Li
Journal:  Front Microbiol       Date:  2011-03-16       Impact factor: 5.640

5.  CD8 T Cell Responses to an Immunodominant Epitope within the Nonstructural Protein NS1 Provide Wide Immunoprotection against Bluetongue Virus in IFNAR-/- Mice.

Authors:  Alejandro Marín-López; Eva Calvo-Pinilla; Diego Barriales; Gema Lorenzo; Alejandro Brun; Juan Anguita; Javier Ortego
Journal:  J Virol       Date:  2018-07-31       Impact factor: 5.103

Review 6.  Viral Vector Vaccines against Bluetongue Virus.

Authors:  Luis Jiménez-Cabello; Sergio Utrilla-Trigo; Eva Calvo-Pinilla; Sandra Moreno; Aitor Nogales; Javier Ortego; Alejandro Marín-López
Journal:  Microorganisms       Date:  2020-12-25

7.  The Combined Expression of the Nonstructural Protein NS1 and the N-Terminal Half of NS2 (NS21-180) by ChAdOx1 and MVA Confers Protection against Clinical Disease in Sheep upon Bluetongue Virus Challenge.

Authors:  Sergio Utrilla-Trigo; Luis Jiménez-Cabello; Eva Calvo-Pinilla; Alejandro Marín-López; Gema Lorenzo; Pedro Sánchez-Cordón; Sandra Moreno; Julio Benavides; Sarah Gilbert; Aitor Nogales; Javier Ortego
Journal:  J Virol       Date:  2021-11-17       Impact factor: 5.103

8.  Protective Efficacy in Sheep of Adenovirus-Vectored Vaccines against Bluetongue Virus Is Associated with Specific T Cell Responses.

Authors:  Verónica Martín; Elena Pascual; Miguel Avia; Lourdes Peña; Félix Valcárcel; Noemí Sevilla
Journal:  PLoS One       Date:  2015-11-30       Impact factor: 3.240

9.  Assessment of cross-protection induced by a bluetongue virus (BTV) serotype 8 vaccine towards other BTV serotypes in experimental conditions.

Authors:  Ludovic Martinelle; Fabiana Dal Pozzo; Christine Thys; Ilse De Leeuw; Willem Van Campe; Kris De Clercq; Etienne Thiry; Claude Saegerman
Journal:  Vet Res       Date:  2018-07-16       Impact factor: 3.683

10.  Implications of a conserved region of bluetongue virus protein VP2 in cross-neutralisation of bluetongue virus serotypes.

Authors:  Shiva J Jyothi; Sunil R Patil; Narasimha Y Reddy; Rao P Panduranga; Uma Madala; Gnana M Prakash; Kalyani Putty
Journal:  Onderstepoort J Vet Res       Date:  2020-10-08       Impact factor: 1.792

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.